West Pharmaceutical Services (WST) makes the stoppers, plungers, and seals inside injectable drug vials — and that regulatory design-in moat makes switching suppliers nearly impossible. Here's the long-term investment case, including biologics, GLP-1, and HVP mix tailwinds.
Align Technology (ALGN) 2026 stock analysis: Invisalign brand moat, iTero scanner razor-blade dynamics, patent expiry competition, teen expansion, and why this medtech trades like a consumer discretionary stock.
STERIS plc 2026 outlook: infection prevention, AST contract sterilization, life sciences — bull/base/bear scenarios, risks, and what to watch.
Becton Dickinson (NYSE: BDX) 2026 investment analysis — consumable-driven moat, Dividend Aristocrat track record, portfolio separation strategy, key risks, and how BD stacks up against Stryker, Medtronic, and peers.
Abbott Laboratories (ABT) stock outlook 2026. FreeStyle Libre CGM dominance, 4-segment diversification, 52-year dividend streak, 50% analyst upside, and price target scenarios for US investors.